Otonomy

December 18, 2020

First-quarter catalysts for the smaller players

Important data releases are on the cards for Rhythm, Wave and Supernus, among others.

Tinnitus hopes put to sleep by latest Auris failure

October 05, 2017

Back to the future for small caps, but not all benefit

Oncology-focused smaller biotechs reap rich rewards, but generics groups face hard times.

January 07, 2016

The biotech whip-rounds start early

May 01, 2015

Upcoming events: Survival data from Glaxo's Breo and Otonomy's move in Ménière’s

October 02, 2014

IPOs surge in Q3 as investor enthusiasm shows no sign of waning

October 17, 2013

Slow quarter for venture funding could dim hopes of a pick-up